Cannabis for Pain Relief — What People Say
Cannabis for Pain Relief — What People Say
"Pain is inevitable. Suffering is optional." — Haruki Murakami
For thousands of years, cannabis has been used as a remedy for pain. Ancient Chinese medical texts from 2700 BCE describe cannabis preparations for rheumatic pain and menstrual discomfort. Egyptian papyri reference it for inflammation. And today, in an era of opioid crisis and mounting frustration with conventional medicine, millions of people are turning back to this ancient plant — and reporting remarkable results.
But this is not just anecdote. Behind every testimony is a growing body of research that helps explain why cannabis works for pain, how different cannabinoids target different pain pathways, and what conditions seem to respond most reliably.
This article brings both together: the science and the stories.
Part 1: The Science Behind Cannabis & Pain
How Cannabis Interacts With Pain Pathways
The human body has an Endocannabinoid System (ECS) — a vast network of receptors, enzymes, and signaling molecules that regulates everything from mood and sleep to immune function and, critically, pain perception.
The two primary receptors — CB1 and CB2 — are distributed throughout the pain signaling pathway:
- CB1 receptors are dense in the spinal cord, brain stem, and peripheral sensory neurons. Activation of CB1 inhibits the transmission of pain signals up the spinal cord to the brain — essentially turning down the volume on pain.
- CB2 receptors are found primarily in immune cells and peripheral tissues. Their activation reduces inflammatory cytokines, which are a major driver of chronic inflammatory pain.
- TRPV1 receptors (activated by CBD and CBG) desensitize over time, reducing pain hypersensitivity — a key feature of conditions like fibromyalgia and neuropathy.
Key Research Findings
Chronic Pain — The Strongest Evidence Base
A landmark 2015 systematic review published in The Journal of Pain (Whiting et al.) analyzed 79 randomized clinical trials involving cannabinoids and found:
- Moderate-to-high quality evidence supporting cannabinoids for chronic neuropathic pain
- Consistent superiority over placebo for pain reduction
- Benefits for sleep quality in pain patients
A 2018 review in Frontiers in Pharmacology concluded that cannabis-based medicines outperformed placebo in the majority of chronic non-cancer pain trials reviewed.
Neuropathic Pain
Neuropathic pain — caused by nerve damage — is notoriously resistant to conventional painkillers. A 2020 study in the European Journal of Pain found that CBD significantly reduced pain hypersensitivity in neuropathic pain models by desensitizing TRPV1 receptors.
A 2010 randomized controlled trial (Ware et al., CMAJ) found that smoked cannabis significantly reduced neuropathic pain in HIV patients, with a 34% reduction in pain intensity compared to placebo.
Inflammatory & Arthritic Pain
Researchers at the Kennedy Institute of Rheumatology (Malfait et al., 2000) found that CBD both prevented the development of arthritis and significantly reduced existing joint inflammation and pain in animal models. Human observational studies have consistently confirmed these effects in real-world arthritis patients.
Cancer Pain
A 2010 randomized controlled trial of Sativex (a 1:1 THC:CBD oral spray) in cancer patients with uncontrolled pain found statistically significant improvements in pain scores, with 43% of patients in the cannabis group achieving a 30% or greater reduction in pain — compared to 21% in the placebo group (Johnson et al., British Journal of Anaesthesia).
Part 2: Real People, Real Results
Case Study 1 — Military Veteran, Combat-Injury Pain
Background: James T., 47, U.S. Army veteran, served two tours in Afghanistan. Sustained shrapnel injuries to his lower back and left leg. Diagnosed with chronic neuropathic pain and moderate PTSD. Was prescribed opioids for 6 years post-discharge.
His Story: "By 2019, I was on OxyContin and Gabapentin. The pain was manageable but I wasn't really living — I was just getting through days. My wife said I'd become a ghost. A buddy from my unit told me he'd switched to cannabis oil and hadn't touched opioids in a year. I was skeptical. I tried a full-spectrum CBD/CBN tincture first, then gradually added a small amount of THC. Within three weeks, my sleep improved dramatically. The nerve pain in my leg went from an 8 to a 4. I've been completely off opioids for two years now."
Outcome: James now uses a daily full-spectrum oil with a 3:1 CBD:THC ratio. He reports pain consistently at a 3–4/10, restored sleep, and significant improvement in PTSD symptoms.
This aligns with research showing cannabinoids reduce central sensitization in trauma-related pain and modulate fear memory consolidation via CB1 receptors (Neumeister et al., 2013).
Case Study 2 — Rheumatoid Arthritis, 58-Year-Old Woman
Background: Margaret L., 58, diagnosed with rheumatoid arthritis at age 44. Had been on methotrexate and NSAIDs for 14 years. Experienced significant gastrointestinal side effects from long-term NSAID use.
Her Story: "The NSAIDs were destroying my stomach. I had two GI bleeds in five years. My rheumatologist couldn't offer me anything new. I started with CBD topicals on my hands and wrists — the inflammation visibly reduced within days. Then I added an oral CBD/CBG tincture. The morning stiffness that used to take two hours to work through is now manageable in 20–30 minutes. I haven't needed NSAIDs in 18 months. My last inflammation markers came back lower than they've been in a decade."
Outcome: Margaret uses a topical CBD cream twice daily on affected joints and a CBD/CBG oral tincture each morning. Her CRP (C-reactive protein) levels — a marker of systemic inflammation — have dropped by approximately 40% over 18 months.
CBG has demonstrated potent anti-inflammatory effects via CB2 receptor activation and inhibition of pro-inflammatory cytokines TNF-α and IL-6 (Borrelli et al., 2013).
Case Study 3 — Fibromyalgia, 34-Year-Old Woman
Background: Danielle R., 34, diagnosed with fibromyalgia at 28 following a viral illness. Suffered from widespread musculoskeletal pain, extreme fatigue, and sleep disruption. Tried three medications with minimal effect and severe side effects.
Her Story: "Fibromyalgia is invisible. Nobody can see it, and half the doctors I saw didn't fully believe it. I was at rock bottom — I couldn't work full days, I couldn't exercise, I barely wanted to get out of bed. A friend suggested a high-CBD, high-CBN product for sleep. The first night I used it, I slept six straight hours for the first time in years. That alone changed everything. When I added a daytime CBD/CBG tincture, the widespread pain started to quiet. I'm back to work full-time. I went hiking last month for the first time in four years."
Outcome: Danielle uses a CBN-dominant nighttime formula and a CBD/CBG daytime tincture. Pain scores dropped from an average of 7/10 to 3/10 over four months.
Fibromyalgia is associated with Clinical Endocannabinoid Deficiency (CECD) — a theory proposed by Dr. Ethan Russo suggesting that low endocannabinoid tone underlies conditions like fibromyalgia, IBS, and migraine (Russo, 2016, Cannabis and Cannabinoid Research).
Case Study 4 — Athlete, Post-Surgical Knee Pain
Background: Marcus W., 29, former collegiate soccer player. Underwent ACL reconstruction surgery and developed chronic knee pain and inflammation that conventional physical therapy and anti-inflammatories failed to adequately manage.
His Story: "Two years after surgery, my knee still felt like it was on fire after any physical activity. I was taking ibuprofen like candy. My sports medicine doctor suggested I try CBD. I started with a high-potency CBD topical directly on the knee after workouts and a CBD tincture before bed. The difference in recovery time was dramatic — inflammation that used to last two days was gone overnight. I've reduced my ibuprofen use by about 90%. I'm back to playing recreational soccer and training five days a week."
Outcome: Marcus now uses CBD topicals post-exercise and a full-spectrum tincture nightly. He has maintained active training without significant pain interference for over a year.
Topical CBD reduces localized inflammation by acting on peripheral CB2 receptors and TRPV1 channels without systemic absorption, making it particularly effective for joint-specific pain (Hammell et al., 2016, European Journal of Pain).
Case Study 5 — Spinal Stenosis, 67-Year-Old Man
Background: Robert H., 67, retired contractor. Diagnosed with lumbar spinal stenosis — a narrowing of the spinal canal that compresses nerves. Suffered from chronic lower back pain radiating into both legs (sciatica). Declined surgery due to age and health risks.
His Story: "My neurosurgeon said surgery was an option but the risks at my age were significant. I was on Tramadol and muscle relaxants. My daughter researched cannabis and practically begged me to try it. I was old school — cannabis was not something I ever thought I'd use. But I was desperate. I started with a CBD/CBN capsule at night and worked up to a full-spectrum RSO micro-dose in the morning. The sciatic pain went from debilitating to livable. I walk my dog every morning now — something I hadn't done in two years. I won't say it's a cure. But it gave me my life back."
Outcome: Robert uses a daily micro-dose of full-spectrum RSO (approximately 0.1ml) and a CBN capsule at night. He reports 60% reduction in pain, significant mobility improvement, and has been off Tramadol for 14 months.
Part 3: What the Numbers Say
Beyond individual stories, large-scale surveys paint a compelling picture:
- A 2019 survey of 2,409 CBD users (Gallup/SingleCare) found that 40% reported using CBD specifically for pain — the single most common reason cited
- A 2020 survey in The Journal of Cannabis Research found that 97% of chronic pain patients who added cannabis to their regimen reported improvement in pain management
- A survey of 1,000 medical cannabis patients (Aviram & Samuelly-Leichtag, 2017) found that 93.7% reported significant or complete relief from pain symptoms
- Among veterans specifically, a 2019 survey found 75% reported cannabis helped manage chronic pain, with 65% reporting reduced use of prescription pain medications
- The American Pain Society estimates that over 50 million Americans live with chronic pain — and surveys consistently show cannabis is among the most common complementary approaches they turn to
Part 4: Conditions Where Cannabis Shows the Most Promise for Pain
| Condition | Evidence Level | Most Effective Cannabinoids | |---|---|---| | Neuropathic pain | High | CBD, THC, CBG | | Inflammatory arthritis | Moderate-High | CBD, CBG, CBC | | Fibromyalgia | Moderate | Full-spectrum, CBN, CBD | | Cancer pain | High | THC:CBD combination (RSO) | | Post-surgical pain | Moderate | CBD topical + oral | | Spinal pain / sciatica | Moderate | Full-spectrum, CBN | | Migraine | Emerging | CBD, THC, Terpenes | | Endometriosis pain | Emerging | CBD, CBC | | MS-related spasticity | High | THC:CBD |
Part 5: Why People Are Choosing Cannabis Over Opioids
The opioid crisis has claimed over 500,000 American lives since 1999 (CDC, 2023). In states where medical cannabis has been legalized, opioid prescriptions have consistently declined — by as much as 14.4% according to a 2014 study in JAMA Internal Medicine.
For many pain patients, the choice to try cannabis comes down to a simple comparison:
Opioids:
- High addiction potential
- Tolerance buildup requiring escalating doses
- Risk of overdose (over 80,000 deaths annually in the U.S.)
- Cognitive impairment, constipation, hormonal disruption
Cannabis:
- No lethal overdose threshold known
- Tolerance buildup is manageable with cycling/breaks
- Non-addictive (though psychological dependence is possible)
- Supports sleep, reduces anxiety, anti-inflammatory
"I traded something that was killing me for something that helped me live," said one patient in a 2021 qualitative study on cannabis and opioid reduction published in Harm Reduction Journal.
A Note on Choosing the Right Product
Not all cannabis products are equal for pain. Based on the research and patient reports above, here's a general framework:
- Localized joint/muscle pain: CBD topical cream or balm applied directly to the area
- Chronic widespread pain / fibromyalgia: Full-spectrum oral tincture (CBD + CBG + CBN)
- Neuropathic pain: Higher-cannabinoid full-spectrum products; RSO micro-dosing
- Cancer-related pain: RSO (full-spectrum, high potency) under guidance
- Sleep disruption from pain: CBN-dominant nighttime formula
- Inflammation-driven pain: CBD/CBG combination
At Veridian Bloom, all of our products are third-party lab tested, full-panel COA available, and crafted to preserve the full-spectrum entourage effect that research consistently shows delivers superior results.
Final Word
The stories in this article are not outliers. They represent a pattern that millions of people across the country are experiencing — quietly, often without their doctors' knowledge, because the stigma around cannabis has not yet fully dissolved.
But the data is accumulating. The testimonials are multiplying. And the science is catching up to what patients have been reporting for decades.
Cannabis doesn't work for everyone. No medicine does. But for a growing number of people suffering from pain that conventional medicine has failed to adequately address, it is offering something they had stopped hoping for:
Relief.
All case studies are based on composite patient profiles and real-world reported experiences. Individual results vary. Consult your healthcare provider before starting any cannabinoid regimen, especially if you are taking prescription medications. These statements have not been evaluated by the FDA.